We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AME icon
676
Ametek
AME
$54B
$4.86M 0.01%
+19,598
New +$4.73M
2026 Q3
0 quarters
MARA icon
677
PUT
MARA Holdings
MARA
$2.54B
$4.83M 0.01%
426,500
– –
2026 Q2
1 quarter
LULU icon
678
PUT
lululemon athletica
LULU
$12.8B
$4.81M 0.01%
50,000
+40,000
+400% +$4.54M
2026 Q2
1 quarter
JACS icon
679
Jackson Acquisition Co II
JACS
$322M
$4.81M 0.01%
443,751
– –
2025 Q1
6 quarters
ABUS icon
680
PUT
Arbutus Biopharma
ABUS
$630M
$4.78M 0.01%
+1,000,000
New +$4.82M
2026 Q3
0 quarters
EWZ icon
681
iShares MSCI Brazil ETF
EWZ
$8.25B
$4.75M 0.01%
127,500
+77,500
+155% +$2.79M
2025 Q4
3 quarters
QXO icon
682
CALL
QXO
QXO
$11.7B
$4.68M 0.01%
+400,000
New +$5.5M
2026 Q3
0 quarters
RAMP icon
683
DELISTED
LiveRamp
RAMP
$4.67M 0.01%
124,359
+18,234
+17% +$688K
2026 Q2
1 quarter
AXIN icon
684
Axiom Intelligence Acquisition Corp 1
AXIN
$283M
$4.66M 0.01%
450,000
– –
2026 Q2
1 quarter
NOW icon
685
ServiceNow
NOW
$94B
$4.66M 0.01%
34,777
+15,832
+84% +$1.95M
2025 Q3
4 quarters
CEPV icon
686
Cantor Equity Partners V
CEPV
$325M
$4.64M 0.01%
450,000
– –
2025 Q4
3 quarters
GRND icon
687
CALL
Grindr
GRND
$2.58B
$4.63M 0.01%
+300,000
New +$4.75M
2026 Q3
0 quarters
SHLS icon
688
Shoals Technologies Group
SHLS
$1.21B
$4.62M 0.01%
+570,650
New +$4.8M
2026 Q3
0 quarters
WHR icon
689
PUT
Whirlpool
WHR
$1.74B
$4.6M 0.01%
+150,000
New +$5.69M
2026 Q3
0 quarters
KORU icon
690
PUT
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$809M
$4.56M 0.01%
228,000
+174,000
+322% +$3.62M
2026 Q2
1 quarter
HCAC icon
691
Hall Chadwick Acquisition Corp
HCAC
$299M
$4.56M 0.01%
450,000
– –
2026 Q2
1 quarter
NKTR icon
692
Nektar Therapeutics
NKTR
$1.18B
$4.54M 0.01%
75,000
-25,000
-25% -$1.76M
2026 Q1
2 quarters
TWLV icon
693
Twelve Seas Investment Co III
TWLV
$237M
$4.53M 0.01%
+450,000
New +$4.52M
2026 Q3
0 quarters
QGEN icon
694
CALL
Qiagen
QGEN
$10.2B
$4.52M 0.01%
103,400
-150,000
-59% -$6.36M
2025 Q1
6 quarters
USDEW icon
695
StablecoinX Warrants
USDEW
$17.6M
$4.48M 0.01%
+867,154
New +$1.23M
2026 Q3
0 quarters
INFQ icon
696
Infleqtion
INFQ
$1.71B
$4.47M 0.01%
331,725
-2,532
-0.8% -$30.6K
2026 Q1
2 quarters
DV icon
697
DoubleVerify
DV
$2.12B
$4.44M 0.01%
+328,805
New +$4.13M
2026 Q3
0 quarters
AMPX.WS icon
698
Amprius Technologies Warrants
AMPX.WS
$139M
$4.43M 0.01%
1,462,989
-436,271
-23% -$1.62M
2024 Q4
7 quarters
NU icon
699
PUT
Nu Holdings
NU
$58.4B
$4.43M 0.01%
+350,000
New +$4.96M
2026 Q3
0 quarters
TDY icon
700
Teledyne Technologies
TDY
$28.9B
$4.35M 0.01%
+7,175
New +$4.56M
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.